Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China.

NCT02143739 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02143739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02143739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 7, 2014
Completion date
September 15, 2016
Enrollment
4,817 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

asthma